$57.37

3.18 (5.87%)

7/8/2008 4:00 PM

Abbott Laboratories (ABT)

CAPS Rating:

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

View Ticker Page (ABT)

Results 1 - 10 of 121 : 1 2 3 4 5 Next »

Recs

6

Avatar TMFHelical (98.85) Submitted: 6/15/06 4:45 AM : Start Price: $41.33 ABT Score: 36.25

I believe medical diagnostics, specifically clinically validated test products is the next great growth area for biotechnology. ABT is a leader in this area, second only to Roche. In addition to the diagnostics, there is a solid pharmaceutical bus...

Report this Post Replies: 0 | Reply | Permalink

Recs

5

Avatar NetscribePhrmtcl (94.13) Submitted: 1/08/07 2:24 AM : Start Price: $48.35 ABT Score: 28.32

‘Do not be fooled by Abbott Laboratories’, an innocuous name. It is one of the top pharmaceutical companies in the world and engages in discovery, development, manufacture, and sale of health care products worldwide. It generates revenues from four s...

Report this Post Replies: 3 | Reply | Permalink

Recs

3

Avatar pazyarte (49.52) Submitted: 11/10/07 12:33 PM : Start Price: $53.47 ABT Score: 19.70

ABT due to be purchased this week. I am bullish on pharmaceuticals and medical equipment stocks. It is what will be greatly needed by Boomers and continues to develop great products both as generics and new over-the counter products. Great future....

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar ibarz (76.48) Submitted: 10/05/06 2:52 PM : Start Price: $45.05 ABT Score: 33.19

This is a must have for healthcare/pharma. A long term hold for its product pipeline, especially in the stent/drug coated stent business it got from Boston Scientific/Guidant deal.
Practically all analyst reports indicate the ABT is the only winner ...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar drugstock2 (39.13) Submitted: 7/21/07 10:07 PM : Start Price: $52.39 ABT Score: 27.01

ABT is poised to become the next market leader in the DES market. BSX and JNJ are already loosing market share in Asia and Europe. Watch for even more growth for Humira with the new indications like treatment of Psoriasis. Margins for the diagnostic ...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar theragnotics (50.10) Submitted: 11/08/07 3:38 PM : Start Price: $53.20 ABT Score: 21.40

FDA advisory panel meets Nov. 29 to decide for approval of the Xience stent (heart stent). Abbott could turn out to be a leader in the drug-coated stent market.
In 2007 rising sales of Abbott's blockbuster Humira (RA drug).
Abbott's pipeline is full ...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar rrgugliotti (85.61) Submitted: 8/26/06 3:21 PM : Start Price: $47.54 ABT Score: 22.58

Abbott Labs has many great products and an excellent pipeline.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar littlered8 (< 20) Submitted: 2/16/07 3:01 PM : Start Price: $50.86 ABT Score: 25.37

My friend has been in a clinical trial for Humira for the treatment of a gastrointestinal autoimmune disease for 4 years, and has had no symptoms or sideeffects. He believes that the drug will soon be marketed for this illness and take off. It alre...

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar boiseidfool (77.47) Submitted: 3/03/07 9:35 AM : Start Price: $51.24 ABT Score: -19.75

Idaho has filed a lawsuit that alleges Abbott Laboratories falsified wholesale drug prices and that the state has overpaid Medicaid reimbursements because of the manipulated drug prices. In the complaint, the Idaho attorney general's office says the...

Report this Post Replies: 0 | Reply | Permalink